Hepatitis C Management in Special Populations
Summary
- AASLD/IDSA and EASL guidance panels recommend highly active DAA regimens for patients with genotype 1 HCV/HIV–coinfection (Management Guidelines)[AASLD-IDSA HCV] (Management Guidelines)[EASL HCV]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content